Electronic Letters to:
|
|
E-letters: Electronic letters published:
-
![[Read eLetter]](/icons/misc/sectionDOWN.gif)
Mother's milk drops for treatment of epiphora in congenital nasolacrimal duct obstruction
- Parijat Chandra, Rajvardhan Azad (5 February 2008)
|
|
|||
|
Parijat Chandra, Assistant Professor Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India, Rajvardhan Azad
Send e-letter to journal:
|
Dear editor, We read with interest the article by Verd S(1) regarding usage of mother's milk (MM) drops to treat epiphora in congenital nasolacrimal duct obstruction (CNLO). It would be interesting to know the methods by which the author prepared sterile eye drops using mother’s breast milk for ocular instillation. They should clarify the earliest time the treatment was started and if colostrum was also used. The number of drops, frequency of instillation, and the total duration for which the treatment was continued needs to be clarified. It is essential standard sterile practices be adopted for use of Mother’s Milk as eye drops. CNLO is characterized by delayed canalization of the nasolacrimal duct (NLD) with resultant epiphora due to stasis and regurgitation of tears. The complete canalization of the NLD is associated with easy passage of tears and spontaneous resolution of epiphora. Though resolution of mucopurulent discharge may be attributed to antibacterial properties of breast milk, the better success rates reported by the author for resolution of epiphora (following complete canalization of NLD) cannot be attributed to mother’s milk drops alone. Maybe a larger randomized controlled clinical trial is needed before mother’s milk is recommended as a treatment modality for congenital nasolacrimal duct obstruction.
References: Conflict of Interest:None declared |
|||